BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1737792)

  • 1. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.
    Grigoriev M; Praseuth D; Robin P; Hemar A; Saison-Behmoaras T; Dautry-Varsat A; Thuong NT; Hélène C; Harel-Bellan A
    J Biol Chem; 1992 Feb; 267(5):3389-95. PubMed ID: 1737792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites.
    Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3501-5. PubMed ID: 8475098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA triplex formation selectively inhibits granulocyte-macrophage colony-stimulating factor gene expression in human T cells.
    Kochetkova M; Shannon MF
    J Biol Chem; 1996 Jun; 271(24):14438-44. PubMed ID: 8662666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes.
    Orson FM; Thomas DW; McShan WM; Kessler DJ; Hogan ME
    Nucleic Acids Res; 1991 Jun; 19(12):3435-41. PubMed ID: 2062658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressant FK-506 specifically inhibits mitogen-induced activation of the interleukin-2 promoter and the isolated enhancer elements NFIL-2A and NF-AT1.
    Banerji SS; Parsons JN; Tocci MJ
    Mol Cell Biol; 1991 Aug; 11(8):4074-87. PubMed ID: 1712901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator conjugates targeted to HIV proviral DNA.
    Giovannangeli C; Perrouault L; Escudé C; Nguyen T; Hélène C
    Biochemistry; 1996 Aug; 35(32):10539-48. PubMed ID: 8756710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.
    John S; Reeves RB; Lin JX; Child R; Leiden JM; Thompson CB; Leonard WJ
    Mol Cell Biol; 1995 Mar; 15(3):1786-96. PubMed ID: 7862168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 15-base acridine-conjugated oligodeoxynucleotide forms triplex DNA with its IL-2R alpha promoter target with greatly improved avidity.
    Klysik J; Kinsey BM; Hua P; Glass GA; Orson FM
    Bioconjug Chem; 1997; 8(3):318-26. PubMed ID: 9177837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of transcription by triple helix-forming oligonucleotides.
    Duval-Valentin G; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1992 Jan; 89(2):504-8. PubMed ID: 1731320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation.
    Perkins ND; Edwards NL; Duckett CS; Agranoff AB; Schmid RM; Nabel GJ
    EMBO J; 1993 Sep; 12(9):3551-8. PubMed ID: 8253080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-helix formation by alpha oligodeoxynucleotides and alpha oligodeoxynucleotide-intercalator conjugates.
    Sun JS; Giovannangeli C; François JC; Kurfurst R; Montenay-Garestier T; Asseline U; Saison-Behmoaras T; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6023-7. PubMed ID: 2068079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin.
    Hayashi T; Ueno Y; Okamoto T
    J Biol Chem; 1993 May; 268(15):11380-8. PubMed ID: 8496188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro.
    Lavrovsky Y; Stoltz RA; Vlassov VV; Abraham NG
    Eur J Biochem; 1996 Jun; 238(2):582-90. PubMed ID: 8681975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin-2 receptor alpha-subunit gene expression by oligonucleotide-directed triple helix formation.
    Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
    C R Acad Sci III; 1993; 316(5):492-5. PubMed ID: 8221232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional inhibition of the bacteriophage T7 early promoter region by oligonucleotide triple helix formation.
    Ross C; Samuel M; Broitman SL
    Biochem Biophys Res Commun; 1992 Dec; 189(3):1674-80. PubMed ID: 1482373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of R kappa B, a novel DNA-binding protein that recognizes the interleukin-2 receptor alpha chain kappa B site.
    Adams BS; Leung KY; Hanley EW; Nabel GJ
    New Biol; 1991 Nov; 3(11):1063-73. PubMed ID: 1777480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence-specific intercalating agents: intercalation at specific sequences on duplex DNA via major groove recognition by oligonucleotide-intercalator conjugates.
    Sun JS; François JC; Montenay-Garestier T; Saison-Behmoaras T; Roig V; Thuong NT; Hélène C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9198-202. PubMed ID: 2594761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer.
    Hiscott J; Alper D; Cohen L; Leblanc JF; Sportza L; Wong A; Xanthoudakis S
    J Virol; 1989 Jun; 63(6):2557-66. PubMed ID: 2542571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.